Report overview
DNA vaccines are the direct application of antigen-encoding DNA vectors.
Introduce into the body, express the protein, and then pass through the cells and body fluids
The immune response to produce antibodies, to achieve a method of prevention and treatment of disease.
This report contains market size and forecasts of Pet DNA Vaccines in global, including the following market information:
Global Pet DNA Vaccines Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Pet DNA Vaccines Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Pet DNA Vaccines companies in 2022 (%)
The global Pet DNA Vaccines market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Type ? Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pet DNA Vaccines include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pet DNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet DNA Vaccines Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Pet DNA Vaccines Market Segment Percentages, by Type, 2022 (%)
Type ?
Type ?
Global Pet DNA Vaccines Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Pet DNA Vaccines Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Dird
Others
Global Pet DNA Vaccines Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Pet DNA Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet DNA Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pet DNA Vaccines revenues share in global market, 2022 (%)
Key companies Pet DNA Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pet DNA Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
